The European Commission has published an article promoting the EU-funded InSilc project aiming to create an in silico clinical trials platform for designing and developing drug-eluting BVS
InSilc project develops an in silico clinical trial platform for designing, developing and assessing drug-eluting bioresorbable vascular scaffolds (BVS), by building on the comprehensive biological and biomedical knowledge and advanced modelling approaches to simulate their implantation performance in the individual cardiovascular physiology.
The project is entering its third year and the interim results on the creation of an in silico clinical trials platform for designing and developing drug eluting BVS are very promising.
In the article recently published on the EC website, you can find all the details.
More information can be found on the project website.